Stanford, California 94305


Purpose:

The goal of this study is to determine the effect of Healing Touch (HT) on the stress, anxiety, and self-efficacy experiences of women undergoing in vitro fertilization (IVF) in a randomized, controlled design. HT is a gentle, non-invasive form of energy-balancing work that promotes relaxation.


Study summary:

Once enrolled, each participant will be randomized to one of three groups: the Healing Touch (HT) treatment arm, the Desensitization Therapy (DT) arm, or the no-intervention arm. Subjects in Group 1 will receive three, 45-minute HT sessions during the first two weeks of their IVF cycle prior to oocyte retrieval. Group 2 will receive three, 45-minute DT sessions during the first two weeks of their IVF cycle prior to oocyte retrieval. Group 3 will receive no intervention. Subjects in Group 3 will be offered two HT sessions after completing study participation. All subjects and their partners will be asked to complete the Spielberger State Trait Anxiety Inventory (STAI), the Perceived Stress Scale (PSS) and the Infertility Self-Efficacy Scale (ISES) at three time points: 1) baseline 2) one day prior to oocyte retrieval and 3) 5-7 days post embryo transfer. In addition, subjects in all groups will complete a short pre-study questionnaire to assess expectation of therapeutic effect, and subjects in the two intervention groups will complete a short post-study questionnaire to evaluate their treatment experience. Demographic and pregnancy outcome data will be collected for all subjects.


Criteria:

Inclusion Criteria:-Age <43 - FSH <= 14 - About to enter an IVF cycle at the Stanford Fertility and Reproductive Medicine Center - Planning a transfer of their own fresh embryos during this cycle - Speak and read English fluently Exclusion Criteria:-Diminished ovarian reserve - Planning to freeze their embryos without embryo transfer during this cycle - Planning to use donor eggs or embryos during this cycle - Concomitant energy work interventions (HT, Reiki, QiGong, acupuncture) planned during the IVF cycle.


NCT ID:

NCT00788502


Primary Contact:

Principal Investigator
Kathy Turner RN, NP
Stanford University

Kathy Turner, RN, NP
Phone: (650) 724-6850
Email: kathyt@stanford.edu


Backup Contact:

N/A


Location Contact:

Stanford, California 94305
United States

Kathy Turner, RN, NP
Phone: 650-724-6850
Email: kathyt@stanford.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.